1. Home
  2. LXFR vs TBPH Comparison

LXFR vs TBPH Comparison

Compare LXFR & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXFR
  • TBPH
  • Stock Information
  • Founded
  • LXFR 1898
  • TBPH 2013
  • Country
  • LXFR United States
  • TBPH United States
  • Employees
  • LXFR N/A
  • TBPH N/A
  • Industry
  • LXFR Major Chemicals
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXFR Industrials
  • TBPH Health Care
  • Exchange
  • LXFR Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • LXFR 380.9M
  • TBPH 452.3M
  • IPO Year
  • LXFR 2012
  • TBPH N/A
  • Fundamental
  • Price
  • LXFR $14.17
  • TBPH $9.32
  • Analyst Decision
  • LXFR
  • TBPH Buy
  • Analyst Count
  • LXFR 0
  • TBPH 4
  • Target Price
  • LXFR N/A
  • TBPH $13.75
  • AVG Volume (30 Days)
  • LXFR 118.2K
  • TBPH 194.0K
  • Earning Date
  • LXFR 02-25-2025
  • TBPH 02-26-2025
  • Dividend Yield
  • LXFR 3.59%
  • TBPH N/A
  • EPS Growth
  • LXFR 57.96
  • TBPH N/A
  • EPS
  • LXFR 0.34
  • TBPH N/A
  • Revenue
  • LXFR $384,400,000.00
  • TBPH $63,192,000.00
  • Revenue This Year
  • LXFR N/A
  • TBPH $11.41
  • Revenue Next Year
  • LXFR $3.44
  • TBPH $37.36
  • P/E Ratio
  • LXFR $45.29
  • TBPH N/A
  • Revenue Growth
  • LXFR N/A
  • TBPH 15.93
  • 52 Week Low
  • LXFR $7.61
  • TBPH $7.44
  • 52 Week High
  • LXFR $15.64
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • LXFR 51.57
  • TBPH 47.75
  • Support Level
  • LXFR $14.11
  • TBPH $8.85
  • Resistance Level
  • LXFR $14.71
  • TBPH $10.05
  • Average True Range (ATR)
  • LXFR 0.41
  • TBPH 0.38
  • MACD
  • LXFR -0.01
  • TBPH 0.01
  • Stochastic Oscillator
  • LXFR 48.03
  • TBPH 38.75

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: